Princeton, New Jersey, October 13, 2010 - Sandoz announced today the launch of pramipexole dihydrochloride tablets, a generic equivalent of Mirapex®, in the US. Pramipexole dihydrochloride tablets are ...

February 23, 2010 — The US Food and Drug Administration (FDA) has approved a new once-daily formulation of pramipexole dihydrochloride (Mirapex ER tablets, Boehringer Ingelheim Pharmaceuticals, Inc) ...

Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg, 4.5mg; tabs. Swallow whole. May take with food. Initially 0.375mg once daily ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

MIRAPEX ER (pramipexole dihydrochloride) extended-release tablets from Boehringer-Ingelheim The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer ...

RIDGEFIELD, Conn., March 23 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER® ...

Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex® Tablets, a Parkinson's disease treatment. Pramipexole ...

The tablets are available in 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in bottle count sizes of 30 Dr Reddy’s Laboratories (DRL) has launched Pramipexole dihydrochloride extended-release tablets ...

Details concerning the Pramipexole Dihydrochloride Monohydrate medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

RIDGEFIELD, Conn., Feb. 22 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole ...